Enzon Pharmaceuticals Inc (OTCMKTS:ENZN) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.18 and traded as high as $0.20. Enzon Pharmaceuticals shares last traded at $0.20, with a volume of 90,359 shares changing hands.
The business’s 50-day simple moving average is $0.17 and its two-hundred day simple moving average is $0.18.
Enzon Pharmaceuticals (OTCMKTS:ENZN) last issued its quarterly earnings data on Thursday, April 30th. The biotechnology company reported ($0.01) earnings per share for the quarter. Enzon Pharmaceuticals had a negative return on equity of 17.93% and a negative net margin of 1,745.90%.
About Enzon Pharmaceuticals (OTCMKTS:ENZN)
Enzon Pharmaceuticals, Inc, together with its subsidiaries, engages in licensing drug products. Its marketed drug products include PegIntron for use in the treatment of chronic hepatitis C; and Sylatron for use in the treatment of melanoma disease. The company was founded in 1981 and is headquartered in Cranford, New Jersey.
Featured Story: Systematic Risk
Receive News & Ratings for Enzon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.